The investment is expected to create approximately 800 new direct jobs and support over 2,200 indirect jobs by 2028.

At the top of the list is a mandate for the Food and Drug Administration to reduce the amount of time it takes to approve domestic pharmaceutical manufacturing plants. The agency is being directed ...

Domestic manufacturing in the pharmaceutical industry has fallen considerably in ... requirements to slash the time it usually takes to approve manufacturing plants in the United States. According to ...

Despite these efforts, skepticism remains within the pharmaceutical industry regarding ... increase fees and inspections for foreign manufacturing plants. However, it lacks specific details ...

“As announced in February, Lilly is actively evaluating manufacturing site locations ... in the U.S., including three active pharmaceutical ingredients plants and one site to produce injectable ...

Sanofi (NASDAQ:SNY), in partnership with Vietnam Vaccine JSC (VNVC), officially launched a state-of-the-art vaccine ...

Coalition members from academia, pharmaceutical manufacturing and the tech industry pose for a ... challenges with real-world impact at the intersection of human, animal and plant health, aimed at ...

VOV.VN - French President Emmanuel Macron and Vietnamese Vice President Vo Thi Anh Xuan launched the groundbreaking ceremony ...

Second annual industry celebration recognises outstanding achievements across Irish manufacturing sector with 17 trophies awarded ...

Lilly—a manufacturer of medicines like Mounjaro, Zepbound and Ebglyss—is considering purchasing 236 acres from Generation ...